AIR OPTIX® plus HydraGlyde® for Astigmatism
Lentile sfero-cilindrice pentru purtare zilnica si cu inlocuire lunara, avand dioptrii de la -10.00 la +6.00, cilindri: -0.75, -1.25, -1.75, -2.25 si intreaga gama de axe, in pas de 10°.
NOU! Contin 2 tehnologii avansate ce asigura confortul:
TEHNOLOGIA SMARTSHIELD formeaza un scut protector impotriva depunerilor, mentinand lentilele curate timp mai indelungat 4,5†
MATRICEA DE HYDRATARE HYDRAGLYDE mentine lentilele de contact umectate pe parcursul intregii zile, in fiecare zi 6,7
Te bucuri de vedere stabila in primele 30 de secunde de la aplicare 8*
Lentilele raman stabile pe ochi intreaga luna, asigurand o vedere clara 2,3**
Confortul de durata si vederea clara fac din aceste lentile de contact o optiune excelenta pentru purtatorii care incearca lentile pentru prima data 1*
Specificatii tehnice
- Material: Lotrafilcon B
- Transmisibilitate la Oxigen (Dk/t): 110 @ - 3.00 D
- Continut apa: 33%
» Pliant
» Link: www.airoptix.com
*Pe baza studiilor clinice efectuate cu lentilele de contact AIR OPTIX® for Astigmatism.
**Pe baza studiilor clinice efectuate cu lentilele de contact sferice AIR OPTIX® AQUA.
†Pe baza studiilor clinice efectuate cu lentilele de contact AIR OPTIX® AQUA, în comparație cu lentilele de contact Biofinity^, PureVision^, ACUVUE^ OASYS, ACUVUE^ ADVANCE, și Avaira^
^Produsele specificate sunt mărci înregistrate.
Referințe: 1. In a randomized, subject-masked, multisite clinical study with over 150 patients; significance demonstrated at the 0.05 level; Alcon data on file, 2005. 2. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93:E-abstract 165256. 3. Eiden SB, Davis R, Bergenske P. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective measures of health, comfort and vision. Eye Contact Lens. 2013;39(4):290-294. 4. Nash W, Gabriel M. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluorometric enzymatic assay. Eye Contact Lens. 2014;40(5):277-282. 5. Nash W, Gabriel M, Mowrey-Mckee M. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010;87:E-abstract 105110. 6. In vitro study over 16 hours to measure wetting substantivity; Alcon data on file, 2015. 7. Lemp J, Kern J. On-eye performance of lotrafilcon B lenses packaged with a substantive wetting agent. Poster presented at Optometry's Meeting, the Annual Meeting of the American Optometric Association; June 21-25, 2017; Washington, D.C. 8. In a randomized, subject-masked clinical study at 11 sites with 83 subjects; significance demonstrated at the 0.05 level; Alcon data on file, 2006.
**Pe baza studiilor clinice efectuate cu lentilele de contact sferice AIR OPTIX® AQUA.
†Pe baza studiilor clinice efectuate cu lentilele de contact AIR OPTIX® AQUA, în comparație cu lentilele de contact Biofinity^, PureVision^, ACUVUE^ OASYS, ACUVUE^ ADVANCE, și Avaira^
^Produsele specificate sunt mărci înregistrate.
Referințe: 1. In a randomized, subject-masked, multisite clinical study with over 150 patients; significance demonstrated at the 0.05 level; Alcon data on file, 2005. 2. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93:E-abstract 165256. 3. Eiden SB, Davis R, Bergenske P. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective measures of health, comfort and vision. Eye Contact Lens. 2013;39(4):290-294. 4. Nash W, Gabriel M. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluorometric enzymatic assay. Eye Contact Lens. 2014;40(5):277-282. 5. Nash W, Gabriel M, Mowrey-Mckee M. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010;87:E-abstract 105110. 6. In vitro study over 16 hours to measure wetting substantivity; Alcon data on file, 2015. 7. Lemp J, Kern J. On-eye performance of lotrafilcon B lenses packaged with a substantive wetting agent. Poster presented at Optometry's Meeting, the Annual Meeting of the American Optometric Association; June 21-25, 2017; Washington, D.C. 8. In a randomized, subject-masked clinical study at 11 sites with 83 subjects; significance demonstrated at the 0.05 level; Alcon data on file, 2006.